Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

SpyGlass Posts Positive Early Data in IOL Clinical Trial.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • المؤلفون: Yuika Yoshida
  • المصدر:
    Orange County Business Journal. 11/18/2024, Vol. 47 Issue 47, p10-10. 1/2p.
  • معلومة اضافية
    • الموضوع:
      CLINICAL trials; EYE drops; INTRAOCULAR pressure; INTRAOCULAR lenses
    • نبذة مختصرة :
      The article highlights SpyGlass Pharma Inc.'s development of an intraocular lens (IOL) that can deliver drugs continuously for up to three years, showing promising results in reducing intraocular pressure (IOP) in glaucoma patients. Topics discussed include the company's clinical trial progress, its approach to treating chronic eye conditions, and the ongoing efforts to commercialize the drug delivery lenses for widespread use.